首页 | 本学科首页   官方微博 | 高级检索  
     


Success rate,efficacy, and safety/tolerability of overnight switching from immediate‐ to extended‐release pramipexole in advanced Parkinson's disease
Authors:A. H. V. Schapira  P. Barone  R. A. Hauser  Y. Mizuno  O. Rascol  M. Busse  C. Debieuvre  M. Fraessdorf  W. Poewe
Affiliation:1. Department of Clinical Neurosciences, University College London Institute of Neurology, , London, UK;2. University of Salerno, , Naples, Italy;3. University of South Florida College of Medicine, , Tampa, FL, USA;4. Kitasato University School of Medicine, , Kanagawa, Japan;5. Clinical Investigation Center INSERM CIC‐9302 and Departments of Clinical Pharmacology and Neurosciences, Toulouse University Hospital, , Toulouse, France;6. Boehringer Ingelheim GmbH, , Ingelheim am Rhein, Germany;7. Boehringer Ingelheim France S.A.S, , Reims, France;8. Innsbruck Medical University, , Innsbruck, Austria
Abstract:
Keywords:extended‐release  Parkinson's disease  pramipexole
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号